Back to Search
Start Over
Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study
- Source :
- The Lancet Diabetes & Endocrinology; November 2022, Vol. 10 Issue: 11 p795-803, 9p
- Publication Year :
- 2022
-
Abstract
- Diabetes is a major public health issue. Because lifetime risk, life expectancy, and years of life lost are meaningful metrics for clinical decision making, we aimed to estimate these measures for type 2 diabetes in the high-income setting.
Details
- Language :
- English
- ISSN :
- 22138587 and 22138595
- Volume :
- 10
- Issue :
- 11
- Database :
- Supplemental Index
- Journal :
- The Lancet Diabetes & Endocrinology
- Publication Type :
- Periodical
- Accession number :
- ejs61922230
- Full Text :
- https://doi.org/10.1016/S2213-8587(22)00252-2